Drug Target Insights is a peer-reviewed english-language open-access journal published by AboutScience Srl in Italy, operating under an open-access model since 2006. The journal covers Therapeutics. Pharmacology.
Authors are required to pay an article processing charge to publish in Drug Target Insights; refer to the journal's APC page for the current rate. Articles are released under the CC BY-NC license (see other journals using this license).
To date, Drug Target Insights has published 162 articles. Articles are minted with DOIs through the prefix 10.4137. All submissions undergo plagiarism screening before peer review.
Keywords
clinical therapeutics, molecular drug targets, disease-specific proteins
At a glance
- Publisher
- AboutScience Srl
- Country
- Italy
- Primary language
- English
- License
- CC BY-NC
- Peer review
- Anonymous peer review
- OA since
- 2006
- Review time
- 8 weeks
- DOI prefix
10.4137- Plagiarism check
- Yes
ISSN
- electronic
- 1177-3928
Frequently asked questions
Is Drug Target Insights peer-reviewed?
Yes — Drug Target Insights operates a Anonymous peer review review process.
Does Drug Target Insights charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate.
What subjects does Drug Target Insights publish?
Drug Target Insights publishes research in Therapeutics. Pharmacology.
What languages does Drug Target Insights accept?
Drug Target Insights accepts manuscripts in English.
What is the ISSN of Drug Target Insights?
ISSN:
1177-3928 (electronic).How do I submit a manuscript to Drug Target Insights?
Submit through the journal's official portal: visit submission page →
How long does peer review take at Drug Target Insights?
Average time from submission to publication is approximately 8 weeks.